[HTML][HTML] Management of Congenital Heart Disease: State of the Art; Part I—ACYANOTIC Heart Defects

PS Rao - Children, 2019 - mdpi.com
Since the description of surgery for patent ductus arteriosus in late 1930s, an innumerable
number of advances have taken place in the management of congenital heart defects …

[HTML][HTML] A meta-analysis of perventricular device closure of perimembranous ventricular septal defect

ZN Hong, Q Chen, LQ Huang, H Cao - Journal of Cardiothoracic Surgery, 2019 - Springer
Background To investigate the safety and efficacy of perventricular device closure of
perimembranous VSD (pmVSD). Methods PubMed and Scopus were searched for studies in …

[HTML][HTML] A comparative study of perventricular and percutaneous device closure treatments for isolated ventricular septal defect: a Chinese single-institution …

XS Huang, ZR Luo, Q Chen, LS Yu, H Cao… - Brazilian Journal of …, 2019 - SciELO Brasil
Objectives: To compare the advantages and disadvantages of perventricular and
percutaneous procedures for treating isolated ventricular septal defect (VSD). Methods: A …

A novel biodegradable occluder for the closure of ventricular septal defects: immediate and medium-term results in a canine model

H Bu, Y Yang, S Hu, Q Wu, X Gong… - … and Thoracic Surgery, 2019 - academic.oup.com
OBJECTIVES The feasibility of an Amplatzer septal occluder closure of ventricular septal
defects (VSDs) under echocardiographic guidance has already been proven. However, the …

Intraoperative device closure of a perimembranous ventricular septal defect using the right thoracic ventricle approach

Q Chen, HF Qiu, GC Zhang, LW Chen - The Annals of Thoracic Surgery, 2019 - Elsevier
Background This study compared the safety and effectiveness of intraoperative device
closure of a perimembranous ventricular septal defect (pmVSD) using the right thoracic …